Clinical Trials Browser

Phase 2 × Recruiting × Breast Diseases × Clear all

NCT06335069 2025-09-24

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Phase 2 Recruiting

Breast Diseases, Breast Neoplasms